LeonaBio, Inc. (LONA) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $597.31M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-9.00K; Retained Earnings (Accumulated Deficit)USD $-563.71M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $594.02M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-13.00K; Retained Earnings (Accumulated Deficit)USD $-544.70M.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $539.55M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.00K; Retained Earnings (Accumulated Deficit)USD $-511.75M.
- 2025-09-30: Common Stock, Value, IssuedUSD $4.00K; Additional Paid in Capital, Common StockUSD $455.65M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.00K; Retained Earnings (Accumulated Deficit)USD $-428.87M.
LeonaBio, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K | $597.31M | $-9.00K | $-563.71M | $33.59M | 3 month · $3.18M | (m) |
| 2026-03-31 | $1.00K | $594.02M | $-13.00K | $-544.70M | $49.30M | 3 month · $662.00K | (m) |
| 2025-12-31 | $1.00K | $539.55M | $-4.00K | $-511.75M | $27.79M | 12 month · $6.10M | (m) |
| 2025-09-30 | $4.00K | $455.65M | $-2.00K | $-428.87M | $26.79M | 3 month · $1.41M | (m) |
| 2025-06-30 | $4.00K | $454.24M | $-3.00K | $-422.25M | $31.99M | 3 month · $1.60M | (m) |
| 2025-03-31 | $4.00K | $452.62M | $-4.00K | $-415.29M | $37.33M | 3 month · $1.64M | (m) |
| 2024-12-31 | $0.00 | $450.99M | $1.00K | $-406.15M | $44.84M | 12 month · $11.05M | (m) |
| 2024-09-30 | $4.00K | $448.72M | $3.00K | $-391.14M | $57.58M | 3 month · $2.94M | (m) |
| 2024-06-30 | $4.00K | $445.77M | $-38.00K | $-362.40M | $83.33M | 3 month · $3.21M | (m) |
| 2024-03-31 | $4.00K | $442.42M | $-137.00K | $-335.54M | $106.74M | 3 month · $2.68M | (m) |
| 2023-12-31 | $4.00K | $439.74M | $-349.00K | $-309.21M | $130.19M | 12 month · $10.62M | (m) |
| 2023-09-30 | $4.00K | $437.36M | $-678.00K | $-281.92M | $154.76M | 3 month · $2.49M | (m) |
| 2023-06-30 | $4.00K | $434.87M | $-939.00K | $-248.95M | $184.98M | 3 month · $3.12M | (m) |
| 2023-03-31 | $4.00K | $431.50M | $-1.03M | $-219.35M | $211.12M | 3 month · $2.78M | (m) |
| 2022-12-31 | $4.00K | $428.62M | $-1.96M | $-191.53M | $235.14M | 12 month · $10.61M | (m) |
| 2022-09-30 | $4.00K | $426.12M | $-2.47M | $-161.40M | $262.25M | 3 month · $2.42M | (m) |
| 2022-06-30 | $4.00K | $423.70M | $-1.93M | $-141.21M | $280.56M | 3 month · $3.10M | (m) |
| 2022-03-31 | $4.00K | $420.30M | $-1.46M | $-116.88M | $301.98M | 3 month · $2.73M | (m) |
| 2021-12-31 | $4.00K | $417.36M | $-388.00K | $-95.89M | $321.08M | 12 month · $4.62M | (m) |
| 2021-09-30 | $4.00K | $415.79M | $4.00K | $-79.56M | $336.24M | 3 month · $1.10M | (m) |
| 2021-06-30 | $4.00K | $414.55M | $37.00K | $-63.88M | $350.71M | 3 month · $1.11M | (m) |
| 2021-03-31 | $4.00K | $413.09M | $28.00K | $-49.91M | $363.22M | 3 month · $974.00K | (m) |
| 2020-12-31 | $3.00K | $315.29M | $33.00K | $-41.04M | $274.28M | 12 month · $633.00K | 12 month · $3.50M |
| 2020-09-30 | $3.00K | $292.80M | $7.00K | $-33.34M | $259.47M | 3 month · $111.00K 9 month · $218.00K | 9 month · $3.50M |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-12.53M | 3 month · $49.00K | 3 month · $3.50M |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-21.29M | 3 month · $58.00K | (m) |
| 2019-12-31 | (m) | $1.36M | (m) | $-21.09M | $-19.72M | 12 month · $253.00K | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | $-18.87M | 3 month · $69.00K 9 month · $189.00K | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | $-17.42M | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $-14.89M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |